These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4318268)

  • 1. [The use of diethylaminoethyl-dextran (DEAE-D) as adjuvant for immunization of guinea pigs with inactivated foot-and-mouth disease (FMD) virus].
    Wittmann G
    Zentralbl Bakteriol Orig; 1970; 213(1):1-8. PubMed ID: 4318268
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiments on vaccination of pigs with ethyl-ethyleneimine (EEI) diethylaminoethyl dextran (DEAE-D) foot-and-mouth disease vaccines. Influence of route of inoculation and dose of antigen on the duration of immunity.
    Wittmann G; Bauer K; Mussgay M
    Arch Gesamte Virusforsch; 1972; 36(3):251-64. PubMed ID: 4336493
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trials of vaccination of pigs with vaccines of inactivated foot-and-mouth disease (FMD) virus. II. Trials with ethyl ethyleneimine (EEI) inactivated virus and diethylaminoethyl dextran as an adjuvant].
    Wittmann G; Bauer K; Mussgay M
    Arch Gesamte Virusforsch; 1970; 29(2):139-58. PubMed ID: 4316760
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
    Herniman KA; Sellers RF
    Arch Gesamte Virusforsch; 1972; 37(1):97-103. PubMed ID: 4336969
    [No Abstract]   [Full Text] [Related]  

  • 5. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 6. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.
    Dalsgaard K
    Arch Gesamte Virusforsch; 1974; 44(3):243-54. PubMed ID: 4365900
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to DEAE-dextran and saponin adjuvanted vaccines.
    Anderson EC; Masters RC; Mowat GN
    Res Vet Sci; 1971 Jul; 12(4):351-7. PubMed ID: 5558542
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D).
    de Leeuw PW; Tiessink JW; Frenkel S
    Zentralbl Veterinarmed B; 1979 Mar; 26(2):85-97. PubMed ID: 231355
    [No Abstract]   [Full Text] [Related]  

  • 9. Some investigations on the adjuvant mechanism of DEAE dextran.
    Wittmann G; Dietzschold B; Bauer K
    Arch Virol; 1975; 47(3):225-35. PubMed ID: 164161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic response of lambs to emulsified foot-and-mouth disease vaccine.
    Cunliffe HR; Graves JH
    Arch Gesamte Virusforsch; 1970; 32(2):261-8. PubMed ID: 4322844
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Testing of the activity of anti-foot-and-mouth disease vaccines].
    Fédida M; Dannacher G; Coudert M; Perrin M; Martel JL
    Dev Biol Stand; 1976; 35():243-70. PubMed ID: 198292
    [No Abstract]   [Full Text] [Related]  

  • 15. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ; Sangar DV; Brown F
    Arch Gesamte Virusforsch; 1972; 39(1):274-83. PubMed ID: 4344146
    [No Abstract]   [Full Text] [Related]  

  • 16. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency testing of foot--and--mouth disease vaccines prepared from strain "C" with different adjuvants.
    Sólyom F; Fazekas A; Czelleng F; Makár A; Roith J
    Dev Biol Stand; 1976; 35():113-5. PubMed ID: 198276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early immunity stages following inoculation of pigs with a foot-and-mouth-disease DEAE dextran vaccine].
    Wittmann G
    Zentralbl Veterinarmed B; 1972 May; 19(5):406-11. PubMed ID: 4340583
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intranasal vaccination of cattle against foot-and-mouth disease].
    Bauer K; Straub OC
    Berl Munch Tierarztl Wochenschr; 1985 Jul; 98(7):247-50. PubMed ID: 2994624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.